According to the Hong Kong Stock Exchange disclosure, as of June 3, BlackRock's long position in SINOPHARM's H shares in…
Zhitong
According to the Hong Kong Stock Exchange disclosure, as of June 3rd, BlackRock's long position in SINOPHARM's H-shares increased from 8.74% to 9.84%
The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.